EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieOpen Access · CC BY 4.0

The effect of sleep restriction therapy for insomnia on REM sleep fragmentation: A secondary analysis of a randomised controlled trial

Leonie Franziska Maurer iD, Rachel Sharman, Colin Alexander Espie iD, Simon David Kyle iD

Journal of Sleep Research · 2024

DOI: 10.1111/jsr.13982 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Journal of Sleep Research, 2024. Verfasst von Leonie Franziska Maurer und 3 weiteren Autor:innen. Beteiligte Einrichtung: Sir Jules Thorn Sleep and Circadian Neuroscience Institute, Nuffield Department of Clinical Neurosciences, University of Oxford, Oxford, UK. Hauptthemen laut MEDLINE: Sleep, REM, Sleep Initiation and Maintenance Disorders. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 24 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Dr Mortimer and Theresa Sackler Foundation, National Institute for Health and Care Research (NIHR) Oxford Biomedical Research Centre (BRC), NIHR Oxford Health BRC.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Rapid eye movement sleep fragmentation is hypothesised to be a reliable feature of insomnia, which may contribute to emotion dysregulation. Sleep restriction therapy, an effective intervention for insomnia, has the potential to reduce rapid eye movement sleep fragmentation through its manipulation of basic sleep–wake processes. We performed secondary data analysis of a randomised controlled trial to examine whether sleep restriction therapy reduces rapid eye movement sleep fragmentation in comparison to a matched control arm. Participants ( n = 56; 39 female, mean age = 40.78 ± 9.08 years) were randomly allocated to 4 weeks of sleep restriction therapy or 4 weeks of time in bed regularisation. Ambulatory polysomnographic recordings were performed at baseline, week 1 and week 4. Arousals during rapid eye movement and non‐rapid eye movement sleep were scored blind to group allocation. The following rapid eye movement sleep fragmentation index was the primary outcome: index 1 = (rapid eye movement arousals + rapid eye movement awakenings + non‐rapid eye movement intrusions)/rapid eye movement duration in hours. Secondary outcomes were two further indices of rapid eye movement sleep fragmentation: index 2 = (rapid eye movement arousals + rapid eye movement awakenings)/rapid eye movement duration in hours; and index 3 = rapid eye movement arousals/rapid eye movement duration in hours. A non‐rapid eye movement fragmentation index was also calculated (non‐rapid eye movement arousals/non‐rapid eye movement duration in hours). Linear‐mixed models were fitted to assess between‐group differences. There was no significant group difference for the primary rapid eye movement fragmentation index at week 1 ( p = 0.097, d = −0.31) or week 4 ( p = 0.741, d = −0.06). There was some indication that secondary indices of rapid eye movement fragmentation decreased more in the sleep restriction therapy group relative to control at week 1 (index 2: p = 0.023, d = −0.46; index 3: p = 0.051, d = −0.39), but not at week 4 ( d ≤ 0.13). No group effects were found for arousals during non‐rapid eye movement sleep. We did not find clear evidence that sleep restriction therapy modifies rapid eye movement sleep fragmentation. Small‐to‐medium effect sizes in the hypothesised direction, across several indices of rapid eye movement fragmentation during early treatment, demand further investigation in future studies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Sleep, REMSleep Initiation and Maintenance DisordersHumansFemaleAdultMiddle AgedSleep DeprivationSleep

Stichwörter der Autor:innen

insomniarandomised controlled trialrapid eye movement sleepsleep restriction therapy

Autor:innen und Institutionen

  • Sir Jules Thorn Sleep and Circadian Neuroscience Institute, Nuffield Department of Clinical Neurosciences, University of Oxford, Oxford, UK.
  • mementor DE GmbH, Leipzig, Germany.
  • Big Health Ltd, London, UK.

ORCID-Profile: Leonie Franziska Maurer, Colin Alexander Espie, Simon David Kyle

Förderung

  • Dr Mortimer and Theresa Sackler Foundation
  • National Institute for Health and Care Research (NIHR) Oxford Biomedical Research Centre (BRC)
  • NIHR Oxford Health BRC
  • NIHR-Health Technology Assessment Programme

Zitieren

APA

Maurer, L. F., Sharman, R., Espie, C. A., & Kyle, S. D. (2024). The effect of sleep restriction therapy for insomnia on REM sleep fragmentation: A secondary analysis of a randomised controlled trial. Journal of Sleep Research. https://doi.org/10.1111/jsr.13982

Vancouver

Maurer LF, Sharman R, Espie CA, Kyle SD. The effect of sleep restriction therapy for insomnia on REM sleep fragmentation: A secondary analysis of a randomised controlled trial. Journal of Sleep Research. 2024. doi:10.1111/jsr.13982

BibTeX
@article{Maurer2024,
  author = {Maurer, Leonie Franziska and Sharman, Rachel and Espie, Colin Alexander and Kyle, Simon David},
  title = {The effect of sleep restriction therapy for insomnia on REM sleep fragmentation: A secondary analysis of a randomised controlled trial},
  journal = {Journal of Sleep Research},
  year = {2024},
  doi = {10.1111/jsr.13982}
}
Kostenlos starten →